642 related articles for article (PubMed ID: 2990062)
21. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
[TBL] [Abstract][Full Text] [Related]
23. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
24. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE
J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148
[TBL] [Abstract][Full Text] [Related]
26. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
27. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
28. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
Zucker MB; Mauss EA
Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
[TBL] [Abstract][Full Text] [Related]
29. The effects of amrinone on human platelet aggregation: evidence that amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasma.
Lippton HL; Horwitz PM; McNamara DB; Ignarro LJ; Landry AZ; Hyman AL; Kadowitz PJ
Prostaglandins Leukot Med; 1985 May; 18(2):193-204. PubMed ID: 3925461
[TBL] [Abstract][Full Text] [Related]
30. Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452
[TBL] [Abstract][Full Text] [Related]
31. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
Simpson AW; Reeves ML; Rink TJ
Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
[TBL] [Abstract][Full Text] [Related]
32. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
[TBL] [Abstract][Full Text] [Related]
33. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet effect of demethyldiisoeugenol.
Liao CH; Ko FN; Kuo YH; Teng CM
Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
[TBL] [Abstract][Full Text] [Related]
35. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
36. Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.
Huzoor-Akbar ; Witiak DT; Newman HA; Fertel RH; Feller DR
Biochem Pharmacol; 1982 Jun; 31(11):2125-8. PubMed ID: 6288050
[TBL] [Abstract][Full Text] [Related]
37. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
White JG; Rao GH; Gerrard JM
Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
[TBL] [Abstract][Full Text] [Related]
38. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
39. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
40. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
